Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

'Biosimilar' legislation proposed in Colorado

Bill would allow pharmacists to substitute generic biotech drugs for brand-name biologicals if patient's doctor has access to the information.

Although they are not even on the market yet in the U.S., biosimilars are already taking center stage when it comes to politics.

Proposed legislation in Colorado would allow pharmacists there to substitute generic biotech drugs for brand-name biologicals if the patient's doctor has access to information about the change.

A similar bill was proposed in 2013, but, according to the Denver Business Journal, "died amid lobbying for and against the measure from big drug companies."

The big difference with the legislation then and now is that drug makers are backing the doctor notification portion of the wording. Previously, some companies argued that notifying the doctor was an unneeded step, and would prevent pharmacists from prescribint a biosimilar.

Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?